SNWV · SANUWAVE Health, Inc. · Metrics
Market Cap
$41.55M
Shares
8.60M
Volume · Oct 20
34.38K
Avg daily vol (3M)
83.9K
SNWV metrics
91 of 122 screener metrics currently available.
Market overview
2 metricsShare price
$4.83
Market cap
$41.55M
Price action
20 metricsPrice change (1W)
-17.3%
Price change (30D)
+8.8%
Price change (3M)
-24.5%
Price change (6M)
-75.8%
Price change (YTD)
-83.8%
Price change (1Y)
-85.8%
Trailing year
Price change (5Y)
—
52-week high
$35.34
52-week low
$4.00
Change from 52-week high
-86.3%
Change from 52-week low
+20.8%
Annualized volatility
89.3%
Annualized volatility (3M)
64.1%
Beta
1.2
RSI (14D)
45.7
Price vs SMA 50
+0.6%
Price vs SMA 200
-66.9%
Avg volume (3M)
83,895
Relative volume
0.7
Average dollar volume
$452,910
Company
3 metricsSector
Healthcare
Industry
Medical Devices
Shares outstanding
8.60M
Valuation
12 metricsP / E (TTM)
5.3
Trailing earnings · reciprocal yield 19.0%
PEG ratio
—
EV / revenue
1.2×
reciprocal yield 84.0%
EV / EBITDA
19.9×
reciprocal yield 5.0%
EV / EBIT
34.9×
reciprocal yield 2.9%
P / sales
1.0×
reciprocal yield 103.2%
P / book
15.3
reciprocal yield 6.5%
FCF yield
9.9%
TTM · current market cap
Buyback yield
—
P / FCF
10.1
reciprocal yield 9.9%
P / operating cash flow
8.2
reciprocal yield 12.2%
Earnings yield
35.8%
Historical valuation
8 metricsP / E historical average (3Y)
—
P / E historical average (5Y)
—
EV / revenue historical average (3Y)
3.6×
reciprocal yield 27.7%
EV / revenue historical average (5Y)
3.6×
reciprocal yield 27.7%
EV / EBIT historical average (3Y)
39.1×
reciprocal yield 2.6%
EV / EBIT historical average (5Y)
39.1×
reciprocal yield 2.6%
EV / EBITDA historical average (3Y)
30.2×
reciprocal yield 3.3%
EV / EBITDA historical average (5Y)
30.2×
reciprocal yield 3.3%
Dividends & buybacks
7 metricsDividend yield
—
Trailing 12 months
Payout ratio
—
Shareholder yield
—
Dividend / share (TTM)
—
Dividend growth YoY
—
Dividend growth streak
—
Last ex-dividend
—
Earnings calendar
2 metricsNext earnings
—
Last earnings
2026-08-07
Profitability
9 metricsGross margin
76.3%
Operating margin
3.4%
Trailing 12 months
Net margin
34.7%
Gross profit (TTM)
$33.60M
Operating profit (TTM)
$1.50M
Net income (TTM)
$15.26M
Trailing 12 months
Diluted EPS (TTM)
$0.92
FCF margin
9.6%
Effective tax rate
—
Growth
11 metricsRevenue growth YoY
-3.1%
Year over year
Net income growth YoY
-223.8%
Revenue (TTM)
$44.02M
Trailing 12 months
EPS growth YoY
—
Shares change YoY
-6.2%
Year over year · fewer shares
Revenue CAGR (3Y)
+38.1%
Revenue CAGR (5Y)
+61.1%
EPS CAGR (3Y)
—
EPS CAGR (5Y)
—
FCF CAGR (3Y)
—
FCF CAGR (5Y)
—
Quality
14 metricsReturn on equity
547.5%
Return on assets
41.7%
Debt / equity
11.2
Current ratio
1.3
EBITDA (TTM)
$2.64M
Free cash flow (TTM)
$4.24M
Quick ratio
0.9
Interest coverage
—
Net debt / EBITDA
3.7
Return on invested capital
—
Trailing 12 months
Net cash
−$9.73M
Latest balance sheet
Cash & equivalents
$9.38M
Total assets
$36.60M
Total debt
$20.51M
Cash flow & spend
7 metricsOperating cash flow (TTM)
$5.22M
Capital expenditures (TTM)
$978,000
R&D (TTM)
$2.24M
SG&A (TTM)
—
Stock compensation (TTM)
$5.89M
R&D / revenue
5.1%
Stock compensation / revenue
13.4%
Ownership (13F)
9 metrics13F filers
49
13F filer change QoQ
-14
Institutional ownership
37.3%
Conviction holders (share of 13F filers)
—
Crowding (high-turnover and private-fund holders)
—
Private-fund adviser ownership
—
Active holders' share change QoQ
—
Holder tenure
—
Price vs estimated holder cost
—
Ownership (registered funds)
1 metricsIndex-fund ownership
7.3%
Short interest
3 metricsShort interest
2.9%
Latest settlement · 3.9 days to cover
Days to cover
3.9d
Short-squeeze score
50 / 100
Insider activity
2 metricsNet insider buying (90D)
—
Insider-sentiment score
—
Risk flags
1 metricsGoing concern
—